BC Innovations | Apr 24, 2014
Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Obesity Iroquois homeobox 3 (IRX3) In vitro and mouse studies suggest decreasing IRX3 expression could help treat obesity. In mice, sequencing and circular chromosome...
Items per page:
1 - 1 of 1